MEKONOS was founded by Anil Narasimha in 2017.

Who are MEKONOS's investors?

MEKONOS's investors include Booster Innovation Fund, Good AI Capital, Matū, TDK Ventures, Elementum Ventures.

How much funding has MEKONOS raised?

MEKONOS has disclosed $29.5M raised across 2 rounds.

MEKONOS is headquartered in San Francisco, US.

San Francisco, US · Founded 2017 · Delaware corporation · 5 known investors

Your email: who you already know at MEKONOS, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the MEKONOS team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Advancing gene and cell therapy delivery systems to address precision targeting challenges in living patients.

MEKONOS was founded in 2017 by Anil Narasimha.

Anil NarasimhaFounder

Kurt Keilhacker Board directorGeneral Partner at Elementum Ventures

Neil TiwariBoard director

Form D private placements

$29.5M disclosed across 2 rounds · 2020–2021

▶$25MraisedNov 2021 · 23 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

▶$4.5MraisedDec 2020 · 16 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

What does MEKONOS do?: Advancing gene and cell therapy delivery systems to address precision targeting challenges in living patients.
Who founded MEKONOS?: MEKONOS was founded by Anil Narasimha in 2017.
Who are MEKONOS's investors?: MEKONOS's investors include Booster Innovation Fund, Good AI Capital, Matū, TDK Ventures, Elementum Ventures.
How much funding has MEKONOS raised?: MEKONOS has disclosed $29.5M raised across 2 rounds.
Where is MEKONOS headquartered?: MEKONOS is headquartered in San Francisco, US.